Optimization of Lentiviral CAR-T transduction using STEMCELL Technologies’ GMP-compatible ImmunoCult™ suite of reagents

STEMCELL offers a suite of GMP reagents suitable for human T-cell culture. The project will test this suite of reagents in a lentiviral transduction workflow and optimize protocols with these reagents in the UBC workflow for the generation of CAR-T Advanced Therapy Medicinal Products. STEMCELL will use the knowledge gained in this project to answer questions from customers working with similar workflows, who wish to use STEMCELL’s ImmunoCult suite.

Faculty Supervisor:

Kelly M. McNagny

Student:

Partner:

STEMCELL Technologies Canada Inc

Discipline:

Life Sciences

Sector:

Health and Related Sciences & Technology; Manufacturing; Mining; Professional, scientific and technical services

University:

The University of British Columbia

Program:

Accelerate

Related projects

Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.

View all
Current openings

Find the perfect opportunity to put your academic skills and knowledge into practice!

Find Projects

Mitacs Partners

The strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.

Government
Academic
Industry
Innovation
International

International

Load More

International

Load More

Join a thriving innovation ecosystem.

Subscribe to our newsletter now!

Subscribe

Mitacs — Return on Innovation

Mitacs is funded by the Government of Canada, the Government of Alberta, the Government of British Columbia, Research Manitoba, the Government of New Brunswick, the Government of Newfoundland and Labrador, the Government of Nova Scotia, the Government of Ontario, Innovation PEI, the Government of Quebec, the Government of Saskatchewan, and the Government of Yukon.